Question-and-Answer Session
Operator
(Operator Instructions) Our first question comes from Jim Reddoch from FBR.
Jim Reddoch - FBR
Well, good afternoon and nice quarter. A couple of quick questions on Aloxi. Where do you think you exited the quarter, market share-wise? I believe you said before that you have thought you were around 40% market share, maybe headed to as high as 60% market share. Where are we now on that trajectory?
I believe, Bill, you said that the inventory was drawn down over the quarter. Had it been overstocked or was it above the mean level exiting Q2 such that you are now below the mean level? How does it look? Thanks.
Lonnie Moulder
Tim, I will talk to the market share question. The market share that we last discussed was approaching 40% overall. We will have in a few weeks the September IMS data, and we need the monthly data in order to compare how we are doing to the other agents in the class. We do get weekly data, but that is only on our own drug.
So I will not be able to update market share for exiting the quarter until we have that October release of IMS data for the month of September. And as far as the 60% share, that is the share that we believe we can grow this franchise to for CINV in the IV and the oral formulation with approximately 6 million -- just over 6 million annual day of chemotherapy doses with about a 60 share. That would give us sales at our anticipated pricing in excess of 500 million at peak, again, for CINV.
Bill will address your other question.
Bill Spengler
Yes, Jim. Actually, the inventory level really came down at the distributor level by about 10 days or so. Both numbers are within normal range. We have an agreement with our distributors that they will not hold more than approximately a month's worth of inventory. They were approximately at that level at the end of the preceding quarter. They are running right down and closer to the two-week level, right now. It has to do with the improved level of revenue during the period.
Jim Reddoch - FBR
So there was no buy-in in advance of the change in reimbursement?
Lonnie Moulder
There was not. And, Jim, there is no need for them to do that. They can get product within 48 hours from us.
- To read the full transcript on Seeking Alpha, click here »
